A study sought to assess if a treatment combination inhibits tumor growth and metastasis in TNBC. Sacituzumab govitecan-related neutropenia can be effectively treated using G-CSF prophylaxis in patients with mTNBC. A study shows how how advancements in diagnostic tools and treatments for ATTR-CM have improved risk profiles. A recent post-hoc analysis of the ATTRibute-CM trial shows the potential for acoramidis in treating ATTR-CM. A study found an overall decline in surgical myectomy with ICD procedures since 2016. Mobile device-based 3D scanning identifies clinically relevant adolescent idiopathic scoliosis deformity. Researchers sought to assess the rate of axillary pCR in TNBC patients. Adding pembrolizumab to conventional neoadjuvant cytotoxic chemotherapy may improve survival outcomes. Researchers assessed the real-world treatment patterns and clinical outcomes of HER+ BC brain metastases. Individuals with metaplastic breast cancer (MpBC) show a distinct molecular phenotype. A study sought to characterize the molecular and immunological features of the androgen receptor in male breast cancer. People with hereditary cancer pathogenic variants for breast cancer may elect to undergo bilateral mastectomy for prevention. The combination of tucatinib and alpelisib is both tolerable and effective at treating patients with HER2-positive MBC. The CEO of UnitedHealthcare's insurance division was gunned down in Midtown in what police are calling a targeted attack. Transcutaneous tibial nerve stimulation is a clinically effective treatment for overactive bladder symptoms. A new study shows that progression from low burden atrial fibrillation (AF) is associated with negative outcomes. Individuals with cardiac implantable electronic devices have a higher risk of tricuspid regurgitation. The U.S. FDA recently approved Attruby (acoramidis) for adults with ATTR-CM to reduce cardiovascular death, hospitalization. A case study highlights the importance of avoiding anchoring bias in the diagnosis of cardiac amyloidosis. The diagnosis of AL amyloidosis requires a high index of suspicion to render a prompt diagnosis and appropriate treatment.